Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Spastic paraplegia-glaucoma-intellectual disability syndrome is characterized by progressive spastic paraplegia, glaucoma and intellectual deficit. It has been described in two families. The second described sibship was born to consanguineous parents. The mode of inheritance is autosomal recessive.
Features include very common findings: Glaucoma, Intellectual disability, Spasticity, and Paraplegia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Intellectual disability, Spasticity, Paraplegia |
Eyes | 1 | Glaucoma |
Biomarker and diagnostic research for spastic paraplegia-glaucoma-intellectual disability syndrome has been reported in the published literature.
Phenotype severity distribution: 4 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spastic paraplegia-glaucoma-intellectual disability syndrome.
95 publications have been identified in PubMed for spastic paraplegia-glaucoma-intellectual disability syndrome. Research spans Case Report / Case Series (46%), Review / Meta-Analysis (30%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 41 | 46% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 6:22 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
27 |
30% |
Laboratory research | 11 | 12% |
Disease patterns and progression | 6 | 7% |
Clinical study results | 2 | 2% |
Other research | 1 | 1% |
Testing and diagnosis research | 1 | 1% |
İcil S (2026). [PMID: 42232678](https://pubmed.ncbi.nlm.nih.gov/42232678/). *Mol Syndromol*. [Epidemiology / Natural History]
Gaberova K (2026). [PMID: 42100784](https://pubmed.ncbi.nlm.nih.gov/42100784/). *Front Psychiatry*. [Case Report / Case Series]
Serpieri V (2026). [PMID: 41720098](https://pubmed.ncbi.nlm.nih.gov/41720098/). *American journal of human genetics*. [Case Report / Case Series]
Fernand SC Sr (2026). [PMID: 42037903](https://pubmed.ncbi.nlm.nih.gov/42037903/). *Cureus*. [Case Report / Case Series]
Faraj R (2026). [PMID: 41960368](https://pubmed.ncbi.nlm.nih.gov/41960368/). *Hum Mutat*. [Basic Science / Preclinical]
Nou-Fontanet L (2026). [PMID: 41933351](https://pubmed.ncbi.nlm.nih.gov/41933351/). *Orphanet journal of rare diseases*. [Review / Meta-Analysis]
Lang LS (2026). [PMID: 41717397](https://pubmed.ncbi.nlm.nih.gov/41717397/). *Pain reports*. [Review / Meta-Analysis]
Moccia M (2026). [PMID: 41484284](https://pubmed.ncbi.nlm.nih.gov/41484284/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Clinical Trial Publication]
Hoskovcova M (2026). [PMID: 41909919](https://pubmed.ncbi.nlm.nih.gov/41909919/). *Movement disorders : official journal of the Movement Disorder Society*. [Review / Meta-Analysis]
Araujo AQC (2026). [PMID: 41551295](https://pubmed.ncbi.nlm.nih.gov/41551295/). *Lancet regional health. Americas*. [Review / Meta-Analysis]
AI-curated news mentioning spastic paraplegia-glaucoma-intellectual disability syndrome
Updated May 14, 2026
A recent study published in PubMed highlights the presence of FTLD-TDP-43 pathology in a patient with spastic paraplegia-30B linked to a homozygous KIF1A variant. This research contributes to the understanding of the genetic underpinnings of motor neuron disease.
A recent study elucidates genotype-structure-phenotype correlations in early-onset spastic paraplegia type 4, highlighting its divergent natural history. This research contributes to understanding the disease's variability and may inform future therapeutic strategies.